HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yun Huang Selected Research

beta-1 Adrenergic Receptors (beta 1 Adrenergic Receptor)

1/2021Paroxetine Attenuates Cardiac Hypertrophy Via Blocking GRK2 and ADRB1 Interaction in Hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yun Huang Research Topics

Disease

71Neoplasms (Cancer)
03/2022 - 10/2004
15Type 2 Diabetes Mellitus (MODY)
06/2021 - 10/2008
14Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2012
13Insulin Resistance
10/2021 - 09/2009
13Carcinogenesis
01/2021 - 07/2006
11Inflammation (Inflammations)
07/2022 - 02/2006
11Infections
06/2022 - 05/2004
11Hypertension (High Blood Pressure)
01/2021 - 10/2009
9Neoplasm Metastasis (Metastasis)
01/2022 - 11/2013
8Breast Neoplasms (Breast Cancer)
03/2022 - 01/2014
8Hypoxia (Hypoxemia)
01/2022 - 11/2010
7COVID-19
01/2022 - 11/2020
7Fibrosis (Cirrhosis)
01/2021 - 09/2010
7Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2019 - 07/2015
6Liver Cirrhosis (Hepatic Cirrhosis)
07/2022 - 11/2013
6Nasopharyngeal Carcinoma
01/2022 - 01/2019
6Melanoma (Melanoma, Malignant)
01/2021 - 12/2015
6Lung Neoplasms (Lung Cancer)
12/2020 - 12/2005
6Neural Tube Defects (Exencephaly)
01/2020 - 11/2017
5Leukemia
12/2020 - 01/2014
5Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020 - 03/2009
4Chronic Obstructive Pulmonary Disease (COPD)
06/2022 - 01/2013
4Heart Diseases (Heart Disease)
01/2022 - 01/2021
4Body Weight (Weight, Body)
12/2021 - 03/2015
4Stomach Neoplasms (Stomach Cancer)
10/2021 - 01/2018
4Pneumonia (Pneumonitis)
03/2021 - 01/2017
4Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 05/2009
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 11/2014
3Liver Diseases (Liver Disease)
01/2022 - 05/2019
3Colonic Neoplasms (Colon Cancer)
01/2022 - 01/2019
3Heart Failure
01/2022 - 09/2016
3Cardiomegaly (Heart Hypertrophy)
01/2022 - 01/2016
3Triple Negative Breast Neoplasms
11/2021 - 04/2018
3Hypoglycemia (Reactive Hypoglycemia)
06/2021 - 03/2016
3Papillary Thyroid Cancer
04/2021 - 04/2013
3Obesity
03/2021 - 02/2012
3Thrombosis (Thrombus)
01/2021 - 11/2013
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 01/2016
3Prostatic Neoplasms (Prostate Cancer)
01/2021 - 01/2018
3Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 01/2013
3Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2019
3Hematologic Neoplasms (Hematological Malignancy)
12/2020 - 10/2014
3Cholangiocarcinoma
10/2020 - 03/2020
3Gestational Diabetes (Gestational Diabetes Mellitus)
07/2020 - 06/2016
3Hyperglycemia
01/2020 - 01/2018
3Ulcerative Colitis
09/2019 - 10/2011
3Peripheral Nervous System Diseases (PNS Diseases)
03/2019 - 07/2015
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2022 - 01/2019

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
06/2022 - 11/2008
15Glucose (Dextrose)FDA LinkGeneric
11/2020 - 10/2008
12Biomarkers (Surrogate Marker)IBA
04/2021 - 05/2009
11Long Noncoding RNAIBA
01/2022 - 04/2013
10Messenger RNA (mRNA)IBA
06/2022 - 12/2005
10DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2009
10Insulin (Novolin)FDA Link
01/2020 - 04/2011
8MicroRNAs (MicroRNA)IBA
01/2022 - 05/2012
7LipidsIBA
07/2022 - 03/2016
7Pharmaceutical PreparationsIBA
11/2021 - 08/2012
6Biological ProductsIBA
01/2022 - 06/2010
5Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2019
5Phosphotransferases (Kinase)IBA
01/2022 - 01/2019
5Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
01/2020 - 09/2018
5CholesterolIBA
01/2019 - 03/2009
4InflammasomesIBA
06/2022 - 01/2019
4CytokinesIBA
06/2022 - 03/2021
4Reactive Oxygen Species (Oxygen Radicals)IBA
03/2022 - 01/2019
4Circular RNAIBA
01/2022 - 01/2018
4RNA (Ribonucleic Acid)IBA
01/2022 - 11/2020
4CateninsIBA
01/2022 - 01/2019
4ChromatinIBA
01/2022 - 06/2010
4Hypoglycemic Agents (Hypoglycemics)IBA
06/2021 - 08/2011
4Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2020 - 11/2013
4Triglycerides (Triacylglycerol)IBA
01/2019 - 05/2011
4Blood Glucose (Blood Sugar)IBA
01/2018 - 05/2011
3Histones (Histone)IBA
01/2022 - 10/2018
3Hemoglobins (Hemoglobin)IBA
01/2022 - 10/2004
3Sorafenib (BAY 43-9006)FDA Link
01/2022 - 01/2019
3Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2022 - 10/2017
3Chimeric Antigen ReceptorsIBA
12/2021 - 12/2020
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2021 - 01/2017
3HMGB1 Protein (HMG1)IBA
11/2021 - 01/2012
3C-Reactive ProteinIBA
05/2021 - 05/2009
3AntigensIBA
02/2021 - 12/2015
3Immune Checkpoint InhibitorsIBA
01/2021 - 01/2019
3Transfer RNA (tRNA)IBA
11/2020 - 01/2020
3FlavonoidsIBA
01/2020 - 07/2006
3Uric Acid (Urate)IBA
07/2019 - 08/2011
3Angiopoietin-Like Protein 8IBA
01/2018 - 06/2016
3bisphenol AIBA
06/2012 - 09/2011
2Small Interfering RNA (siRNA)IBA
06/2022 - 04/2018
2MethyltransferasesIBA
06/2022 - 01/2021
2CalciumIBA
01/2022 - 09/2011
2Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
01/2022 - 01/2017

Therapy/Procedure

28Therapeutics
01/2022 - 12/2006
9Immunotherapy
01/2022 - 12/2011
7Drug Therapy (Chemotherapy)
01/2022 - 12/2015
4Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 09/2009
4Radiotherapy
01/2021 - 06/2011
3Aftercare (After-Treatment)
01/2022 - 11/2003
3Hepatectomy
01/2021 - 01/2019